<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36614144</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>31</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">704</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24010704</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disorder characterized by selective loss of lower and upper motor neurons (MNs) in the brain and spinal cord, resulting in paralysis and eventually death due to respiratory insufficiency. Although the fundamental physiological mechanisms underlying ALS are not completely understood, the key neuropathological hallmarks of ALS pathology are the aggregation and accumulation of ubiquitinated protein inclusions within the cytoplasm of degenerating MNs. Herein, we discuss recent insights into the molecular mechanisms that lead to the accumulation of protein aggregates in ALS. This will contribute to a better understanding of the pathophysiology of the disease and may open novel avenues for the development of therapeutic strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duranti</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0631-3676</Identifier><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villa</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2730-5974</Identifier><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020-ATE-0024</GrantID><Agency>University of Milano-Bicocca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aggregation</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36614144</ArticleId><ArticleId IdType="pmc">PMC9820914</ArticleId><ArticleId IdType="doi">10.3390/ijms24010704</ArticleId><ArticleId IdType="pii">ijms24010704</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kruger D. Amyotrophic lateral sclerosis. JAAPA. 2012;25:53&#x2013;54. doi: 10.1097/01720610-201207000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01720610-201207000-00013</ArticleId><ArticleId IdType="pubmed">22894036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P., Corcia P., Lautrette G., Nicol M., Preux P.M., Marin B. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Rev. Neurol. 2016;172:37&#x2013;45. doi: 10.1016/j.neurol.2015.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2015.11.002</ArticleId><ArticleId IdType="pubmed">26727307</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Shen D., Gao Y., Zhou Q., Ni Y., Meng H., Shi H., Le W., Chen S. A perspective on therapies for amyotrophic lateral sclerosis: Can disease progression be curbed? Transl. Neurodegener. 2021;10:29. doi: 10.1186/s40035-021-00250-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00250-5</ArticleId><ArticleId IdType="pmc">PMC8353789</ArticleId><ArticleId IdType="pubmed">34372914</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Sayana P., Zhang X., Le W. Genetics of amyotrophic lateral sclerosis: An update. Mol. Neurodegener. 2013;8:28. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Weishaupt J.H. Update on amyotrophic lateral sclerosis genetics. Curr. Opin. Neurol. 2019;32:735&#x2013;739. doi: 10.1097/WCO.0000000000000737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000737</ArticleId><ArticleId IdType="pubmed">31335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L., Plotkin S.S., Yerbury J.J., Cashman N.R. Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:262. doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Groen E.J., Koppers M., van den Berg L.H., Pasterkamp R.J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N., Pandey U.B. Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand. Front. Mol. Neurosci. 2017;10:263. doi: 10.3389/fnmol.2017.00263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00263</ArticleId><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007;61:427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851&#x2013;1854. doi: 10.1126/science.281.5384.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler A.D., Dhillon P., Shorter J. Neurodegenerative disease: Models, mechanisms, and a new hope. Dis. Model. Mech. 2017;10:499&#x2013;502. doi: 10.1242/dmm.030205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.030205</ArticleId><ArticleId IdType="pmc">PMC5451177</ArticleId><ArticleId IdType="pubmed">28468935</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;hn A., Tramutola A., Cascella R. Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress. Oxid. Med. Cell. Longev. 2020;2020:5497046. doi: 10.1155/2020/5497046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5497046</ArticleId><ArticleId IdType="pmc">PMC7140146</ArticleId><ArticleId IdType="pubmed">32308803</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 2003;4:49&#x2013;60. doi: 10.1038/nrn1007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1007</ArticleId><ArticleId IdType="pubmed">12511861</ArticleId></ArticleIdList></Reference><Reference><Citation>Takalo M., Salminen A., Soininen H., Hiltunen M., Haapasalo A. Protein aggregation and degradation mechanisms in neurodegenerative diseases. Am. J. Neurodegener. Dis. 2013;2:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3601466</ArticleId><ArticleId IdType="pubmed">23516262</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyckaerts C., Delatour B., Potier M.C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118:5&#x2013;36. doi: 10.1007/s00401-009-0532-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0532-1</ArticleId><ArticleId IdType="pubmed">19381658</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Strong M.J. Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment. Amyotroph. Lateral Scler. 2012;13:178&#x2013;193. doi: 10.3109/17482968.2011.622405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.622405</ArticleId><ArticleId IdType="pubmed">22214313</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei Y., Oguchi K., Koshihara H., Hineno A., Nakamura A., Ohara S. &#x3b1;-Synuclein coaggregation in familial amyotrophic lateral sclerosis with SOD1 gene mutation. Hum. Pathol. 2013;44:1171&#x2013;1176. doi: 10.1016/j.humpath.2012.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2012.10.024</ArticleId><ArticleId IdType="pubmed">23352207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A., Kwon Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015;47:e147. doi: 10.1038/emm.2014.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.117</ArticleId><ArticleId IdType="pmc">PMC4351408</ArticleId><ArticleId IdType="pubmed">25766616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury P.T., Lashuel H.A. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature. 2006;443:774&#x2013;779. doi: 10.1038/nature05290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05290</ArticleId><ArticleId IdType="pubmed">17051203</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M., Ferri A., Carr&#xec; M.T. Amyotrophic lateral sclerosis: From current developments in the laboratory to clinical implications. Antioxid. Redox Signal. 2008;10:405&#x2013;443. doi: 10.1089/ars.2007.1760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2007.1760</ArticleId><ArticleId IdType="pubmed">18370853</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S., Cova E., Cereda C., Ceroni M., Donetti E., Bosco D.A., Trotti D., Pasinelli P. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. USA. 2012;109:5074&#x2013;5079. doi: 10.1073/pnas.1115402109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115402109</ArticleId><ArticleId IdType="pmc">PMC3324021</ArticleId><ArticleId IdType="pubmed">22416121</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker S.J., Meyerowitz J., James J.L., Liddell J.R., Crouch P.J., Kanninen K.M., White A.R. Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates. Neurochem. Int. 2012;60:415&#x2013;424. doi: 10.1016/j.neuint.2012.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2012.01.019</ArticleId><ArticleId IdType="pubmed">22306778</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Hilton J.B., Hare D.J., Crouch P.J., Double K.L. Superoxide Dismutase 1 in Health and Disease: How&#x2009;a&#x2009;Frontline Antioxidant Becomes Neurotoxic. Angew. Chem. Int. Ed. 2021;60:9215&#x2013;9246. doi: 10.1002/anie.202000451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202000451</ArticleId><ArticleId IdType="pmc">PMC8247289</ArticleId><ArticleId IdType="pubmed">32144830</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S., Goizet C., Soulages A., Vallat J.M., Masson G.L. Genetics of amyotrophic lateral sclerosis: A review. J. Neurol. Sci. 2019;399:217&#x2013;226. doi: 10.1016/j.jns.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.030</ArticleId><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Diaz Z., Fang X., Hart M.P., Chesi A., Shorter J., Gitler A.D. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 2011;9:e1000614. doi: 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>King O.D., Gitler A.D., Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012;1462:61&#x2013;80. doi: 10.1016/j.brainres.2012.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.01.016</ArticleId><ArticleId IdType="pmc">PMC3372647</ArticleId><ArticleId IdType="pubmed">22445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi M.R., Sadat Moslehian M., Sabaie H., Jalaiei A., Ghafouri-Fard S., Taheri M., Rezazadeh M. Stress Granules and Neurodegenerative Disorders: A Scoping Review. Front. Aging Neurosci. 2021;13:650740. doi: 10.3389/fnagi.2021.650740.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.650740</ArticleId><ArticleId IdType="pmc">PMC8261063</ArticleId><ArticleId IdType="pubmed">34248597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Attarwala I.Y., Xie X.Q. SQSTM1/p62: A Potential Target for Neurodegenerative Disease. ACS Chem. Neurosci. 2019;10:2094&#x2013;2114. doi: 10.1021/acschemneuro.8b00516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.8b00516</ArticleId><ArticleId IdType="pmc">PMC6712989</ArticleId><ArticleId IdType="pubmed">30657305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocaturk N.M., Gozuacik D. Crosstalk Between Mammalian Autophagy and the Ubiquitin-Proteasome System. Front. Cell Dev. Biol. 2018;6:128. doi: 10.3389/fcell.2018.00128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2018.00128</ArticleId><ArticleId IdType="pmc">PMC6175981</ArticleId><ArticleId IdType="pubmed">30333975</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Buettner G.R. Superoxide dismutase in redox biology: The roles of superoxide and hydrogen peroxide. Anticancer Agents Med. Chem. 2011;11:341&#x2013;346. doi: 10.2174/187152011795677544.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152011795677544</ArticleId><ArticleId IdType="pmc">PMC3131414</ArticleId><ArticleId IdType="pubmed">21453242</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukai T., Ushio-Fukai M. Superoxide dismutases: Role in redox signaling, vascular function, and diseases. Antioxid. Redox Signal. 2011;15:1583&#x2013;1606. doi: 10.1089/ars.2011.3999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2011.3999</ArticleId><ArticleId IdType="pmc">PMC3151424</ArticleId><ArticleId IdType="pubmed">21473702</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S.J., McKeown S.R., Rashid S. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene. 2016;577:109&#x2013;118. doi: 10.1016/j.gene.2015.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo C.A., Xu Z., Borchelt D.R., Price D.L., Sisodia S.S., Cleveland D.W. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. USA. 1995;92:954&#x2013;958. doi: 10.1073/pnas.92.4.954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.4.954</ArticleId><ArticleId IdType="pmc">PMC42615</ArticleId><ArticleId IdType="pubmed">7862672</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O., Shatunov A., Jones A.R., Andersen P.M., Powell J.F., Al-Chalabi A. Development of a Smartphone App for a Genetics Website: The Amyotrophic Lateral Sclerosis Online Genetics Database (ALSoD) JMIR Mhealth Uhealth. 2013;1:e18. doi: 10.2196/mhealth.2706.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/mhealth.2706</ArticleId><ArticleId IdType="pmc">PMC4114449</ArticleId><ArticleId IdType="pubmed">25098641</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdy&#x144;ski M., Miszta P., Safranow K., Andersen P.M., Morita M., Filipek S., &#x17b;ekanowski C., Ku&#x17a;ma-Kozakiewicz M. SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci. Rep. 2022;12:103. doi: 10.1038/s41598-021-03891-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03891-8</ArticleId><ArticleId IdType="pmc">PMC8742055</ArticleId><ArticleId IdType="pubmed">34996976</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 2006;6:37&#x2013;46. doi: 10.1007/s11910-996-0008-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-996-0008-9</ArticleId><ArticleId IdType="pubmed">16469270</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Morfini G., Karabacak N.M., Song Y., Gros-Louis F., Pasinelli P., Goolsby H., Fontaine B.A., Lemay N., McKenna-Yasek D., et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 2010;13:1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Guest W.C., Yanai A., Pokrishevsky E., O&#x2019;Neill M.A., Gibbs E., Semenchenko V., Yousefi M., Wishart D.S., Plotkin S.S., et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl. Acad. Sci. USA. 2011;108:16398&#x2013;16403. doi: 10.1073/pnas.1102645108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Tattum M.H., Jones S., Collinge J., Fisher E.M., Jackson G.S. Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS ONE. 2010;5:e10627. doi: 10.1371/journal.pone.0010627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010627</ArticleId><ArticleId IdType="pmc">PMC2869360</ArticleId><ArticleId IdType="pubmed">20498711</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovi&#x107; A., Delves H.T., Robberecht W., Tilkin P., Enayat Z.E., Shaw C.E., Stevi&#x107; Z., Apostolski S., Powell J.F., Leigh P.N. Copper and zinc levels in familial amyotrophic lateral sclerosis patients with CuZnSOD gene mutations. Ann. Neurol. 1997;42:130&#x2013;131. doi: 10.1002/ana.410420124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420124</ArticleId><ArticleId IdType="pubmed">9225698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N., Tiloca C., Morelli C., Colombrita C., Poletti B., Doretti A., Maderna L., Messina S., Ratti A., Silani V. Genetics of familial Amyotrophic lateral sclerosis. Arch. Ital. Biol. 2011;149:65&#x2013;82. doi: 10.4449/aib.v149i1.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.4449/aib.v149i1.1262</ArticleId><ArticleId IdType="pubmed">21412717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou S.H., Wu F., Harrich D., Garc&#xed;a-Mart&#xed;nez L.F., Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 1995;69:3584&#x2013;3596. doi: 10.1128/jvi.69.6.3584-3596.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.6.3584-3596.1995</ArticleId><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami I., Arai T., Hasegawa M. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol. 2019;138:751&#x2013;770. doi: 10.1007/s00401-019-02077-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02077-x</ArticleId><ArticleId IdType="pmc">PMC6800885</ArticleId><ArticleId IdType="pubmed">31555895</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;R64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi B., Hartmann H., May S., M&#xf6;hl C., Ederle H., Michaelsen M., Schludi M.H., Dormann D., Edbauer D. Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD. Hum. Mol. Genet. 2017;26:790&#x2013;800. doi: 10.1093/hmg/ddw432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw432</ArticleId><ArticleId IdType="pmc">PMC5409121</ArticleId><ArticleId IdType="pubmed">28040728</ArticleId></ArticleIdList></Reference><Reference><Citation>Law W.J., Cann K.L., Hicks G.G. TLS, EWS and TAF15: A model for transcriptional integration of gene expression. Brief. Funct. Genom. 2006;5:8&#x2013;14. doi: 10.1093/bfgp/ell015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/ell015</ArticleId><ArticleId IdType="pubmed">16769671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., De Conti L., Avenda&#xf1;o-V&#xe1;zquez S.E., Dhir A., Romano M., D&#x2019;Ambrogio A., Tollervey J., Ule J., Baralle M., Buratti E., et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011;30:277&#x2013;288. doi: 10.1038/emboj.2010.310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.310</ArticleId><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruijs da Silva L.A., Simonetti F., Hutten S., Riemenschneider H., Sternburg E.L., Pietrek L.M., Gebel J., D&#xf6;tsch V., Edbauer D., Hummer G., et al. Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation. EMBO J. 2022;41:e108443. doi: 10.15252/embj.2021108443.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108443</ArticleId><ArticleId IdType="pmc">PMC9016352</ArticleId><ArticleId IdType="pubmed">35112738</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis&#x2014;A model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B., Robinson J.L., Irwin D.J., Grossman M., Suh E., Van Deerlin V.M., Wood E.M., Baek Y., et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Arai K., Del Tredici K., Toledo J.B., Robinson J.L., Lee E.B., Kuwabara S., Shibuya K., Irwin D.J., Fang L., et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2013;437. doi: 10.1007/s00401-014-1299-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Rademakers R. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr. Opin. Neurol. 2008;21:693&#x2013;700. doi: 10.1097/WCO.0b013e3283168d1d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e3283168d1d</ArticleId><ArticleId IdType="pmc">PMC2869081</ArticleId><ArticleId IdType="pubmed">18989115</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden Broeck L., Callaerts P., Dermaut B. TDP-43-mediated neurodegeneration: Towards a loss-of-function hypothesis? Trends Mol. Med. 2014;20:66&#x2013;71. doi: 10.1016/j.molmed.2013.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2013.11.003</ArticleId><ArticleId IdType="pubmed">24355761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H., Dormann D. TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 2017;591:1489&#x2013;1507. doi: 10.1002/1873-3468.12646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12646</ArticleId><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Ray P., Rao E.J., Shi C., Guo W., Chen X., Woodruff E.A., 3rd, Fushimi K., Wu J.Y. A Drosophila model for TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2010;107:3169&#x2013;3174. doi: 10.1073/pnas.0913602107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913602107</ArticleId><ArticleId IdType="pmc">PMC2840283</ArticleId><ArticleId IdType="pubmed">20133767</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Xu Y.F., Dickey C.A., Buratti E., Baralle F., Bailey R., Pickering-Brown S., Dickson D., Petrucelli L. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 2007;27:10530&#x2013;10534. doi: 10.1523/JNEUROSCI.3421-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3421-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673167</ArticleId><ArticleId IdType="pubmed">17898224</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Cicardi M.E., Ramesh N., Seguin S.J., Ganassi M., Bigi I., Diacci C., Zelotti E., Baratashvili M., Gregory J.M., et al. The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity. Hum. Mol. Genet. 2016;25:3908&#x2013;3924. doi: 10.1093/hmg/ddw232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw232</ArticleId><ArticleId IdType="pmc">PMC5291228</ArticleId><ArticleId IdType="pubmed">27466192</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella A.E., Zerze G.H., Mittal J., Fawzi N.L. ALS Mutations Disrupt Phase Separation Mediated by &#x3b1;-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. Structure. 2016;24:1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S., Hyman A.A. Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nat. Rev. Mol. Cell Biol. 2021;22:196&#x2013;213. doi: 10.1038/s41580-020-00326-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00326-6</ArticleId><ArticleId IdType="pubmed">33510441</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Ren X., Dunn J.R., Peters A., Miyagi M., Fujioka H., Zhao F., Askwith C., Liang J., et al. Translational regulation in the brain by TDP-43 phase separation. J. Cell Biol. 2021;220:e202101019. doi: 10.1083/jcb.202101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202101019</ArticleId><ArticleId IdType="pmc">PMC8404466</ArticleId><ArticleId IdType="pubmed">34427634</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.J., Lin H.X., Liu G.L., Tao Q.Q., Ni W., Xiao B.G., Wu Z.Y. The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Clin. Genet. 2017;92:267&#x2013;273. doi: 10.1111/cge.13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13015</ArticleId><ArticleId IdType="pubmed">28429524</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson N.A., Jr., Pandey U.B. FUS-related proteinopathies: Lessons from animal models. Brain Res. 2012;1462:44&#x2013;60. doi: 10.1016/j.brainres.2012.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.01.039</ArticleId><ArticleId IdType="pubmed">22342159</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Kim J.R., van Bruggen R., Park J. RNA-Binding Proteins in Amyotrophic Lateral Sclerosis. Mol. Cells. 2018;41:818&#x2013;829. doi: 10.14348/molcells.2018.0243.</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2018.0243</ArticleId><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson M.K., St&#xe5;hlberg A., Arvidsson Y., Olofsson A., Semb H., Stenman G., Nilsson O., Aman P. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 2008;9:37. doi: 10.1186/1471-2121-9-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2121-9-37</ArticleId><ArticleId IdType="pmc">PMC2478660</ArticleId><ArticleId IdType="pubmed">18620564</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., Gao K., Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 2014;10:337&#x2013;348. doi: 10.1038/nrneurol.2014.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S., Cleveland D.W. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol. 2011;21:904&#x2013;919. doi: 10.1016/j.conb.2011.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2011.05.029</ArticleId><ArticleId IdType="pmc">PMC3228892</ArticleId><ArticleId IdType="pubmed">21813273</ArticleId></ArticleIdList></Reference><Reference><Citation>Chook Y.M., S&#xfc;el K.E. Nuclear import by karyopherin-&#x3b2;s: Recognition and inhibition. Biochim. Biophys. Acta. 2011;1813:1593&#x2013;1606. doi: 10.1016/j.bbamcr.2010.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2010.10.014</ArticleId><ArticleId IdType="pmc">PMC3135726</ArticleId><ArticleId IdType="pubmed">21029754</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M.E., Mackenzie I.R., Capell A., Schmid B., et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010;29:2841&#x2013;2857. doi: 10.1038/emboj.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson N.A., Jr., Maltare A., King H., Smith R., Kim J.H., Taylor J.P., Lloyd T.E., Pandey U.B. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum. Mol. Genet. 2011;20:2510&#x2013;2523. doi: 10.1093/hmg/ddr150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr150</ArticleId><ArticleId IdType="pmc">PMC4288133</ArticleId><ArticleId IdType="pubmed">21487023</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M., et al. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M., Hutten S., Bourgeois B., Spreitzer E., Niedner-Boblenz A., Schifferer M., Ruepp M.D., Simons M., Niessing D., Madl T., et al. Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation. Cell. 2018;173:706&#x2013;719.e713. doi: 10.1016/j.cell.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.004</ArticleId><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo F., Gui X., Zhou H., Gu J., Li Y., Liu X., Zhao M., Li D., Li X., Liu C. Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation. Nat. Struct. Mol. Biol. 2018;25:341&#x2013;346. doi: 10.1038/s41594-018-0050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0050-8</ArticleId><ArticleId IdType="pubmed">29610493</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray D.T., Kato M., Lin Y., Thurber K.R., Hung I., McKnight S.L., Tycko R. Structure of FUS Protein Fibrils and Its Relevance to Self-Assembly and Phase Separation of Low-Complexity Domains. Cell. 2017;171:615&#x2013;627.e616. doi: 10.1016/j.cell.2017.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.08.048</ArticleId><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T., Ali R., Jiou J., Fung H.Y.J., Burke K.A., Kim S.J., Lin Y., Peeples W.B., Saltzberg D., Soniat M., et al. Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites. Cell. 2018;173:693&#x2013;705.e622. doi: 10.1016/j.cell.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.003</ArticleId><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan P., Parkash A., Islam A., Ahmad F., Hassan M.I. Molecular basis of the structural stability of hemochromatosis factor E: A combined molecular dynamic simulation and GdmCl-induced denaturation study. Biopolymers. 2016;105:133&#x2013;142. doi: 10.1002/bip.22760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.22760</ArticleId><ArticleId IdType="pubmed">26537310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognesi B., Faure A.J., Seuma M., Schmiedel J.M., Tartaglia G.G., Lehner B. The mutational landscape of a prion-like domain. Nat. Commun. 2019;10:4162. doi: 10.1038/s41467-019-12101-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12101-z</ArticleId><ArticleId IdType="pmc">PMC6744496</ArticleId><ArticleId IdType="pubmed">31519910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T.W., Xie S., Shi K., Du X., Wu L.C., Mirzaei H., Goldsmith E.J., Longgood J., Pei J., et al. Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767. doi: 10.1016/j.cell.2012.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Udan-Johns M., Bengoechea R., Bell S., Shao J., Diamond M.I., True H.L., Weihl C.C., Baloh R.H. Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Hum. Mol. Genet. 2014;23:157&#x2013;170. doi: 10.1093/hmg/ddt408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt408</ArticleId><ArticleId IdType="pmc">PMC3857952</ArticleId><ArticleId IdType="pubmed">23962724</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E., Neumann M., Tahirovic S., Rodde R., Dormann D., Haass C. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43) J. Biol. Chem. 2012;287:23079&#x2013;23094. doi: 10.1074/jbc.M111.328757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.328757</ArticleId><ArticleId IdType="pmc">PMC3391091</ArticleId><ArticleId IdType="pubmed">22563080</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause L.J., Herrera M.G., Winklhofer K.F. The Role of Ubiquitin in Regulating Stress Granule Dynamics. Front. Physiol. 2022;13:910759. doi: 10.3389/fphys.2022.910759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.910759</ArticleId><ArticleId IdType="pmc">PMC9174786</ArticleId><ArticleId IdType="pubmed">35694405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B., Ivanov P. Stress granules and neurodegeneration. Nat. Rev. Neurosci. 2019;20:649&#x2013;666. doi: 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Ngo S.T. Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis. Metabolites. 2022;12:709. doi: 10.3390/metabo12080709.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12080709</ArticleId><ArticleId IdType="pmc">PMC9415507</ArticleId><ArticleId IdType="pubmed">36005581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuiji H., Iguchi Y., Furuya A., Kataoka A., Hatsuta H., Atsuta N., Tanaka F., Hashizume Y., Akatsu H., Murayama S., et al. Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol. Med. 2013;5:221&#x2013;234. doi: 10.1002/emmm.201202303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202303</ArticleId><ArticleId IdType="pmc">PMC3569639</ArticleId><ArticleId IdType="pubmed">23255347</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran-Heravi Y., Van Broeckhoven C., van der Zee J. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum. Neurobiol. Dis. 2020;134:104639. doi: 10.1016/j.nbd.2019.104639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104639</ArticleId><ArticleId IdType="pubmed">31626953</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T., Chen S., Yu Y., Yan B., Haertlein T.C., Carrasco M.A., Tapia J.C., Zhai B., Das R., Lalancette-Hebert M., et al. FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2012;2:799&#x2013;806. doi: 10.1016/j.celrep.2012.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.08.025</ArticleId><ArticleId IdType="pmc">PMC3483417</ArticleId><ArticleId IdType="pubmed">23022481</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster C.P., Smith E.F., Shaw P.J., De Vos K.J. Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities? Front. Mol. Neurosci. 2017;10:123. doi: 10.3389/fnmol.2017.00123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00123</ArticleId><ArticleId IdType="pmc">PMC5411428</ArticleId><ArticleId IdType="pubmed">28512398</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel L., Avequin T., Delarue M., Feuillette S., Fr&#xe9;bourg T., Campion D., Lecourtois M. Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila. Neurobiol. Aging. 2012;33:e1001&#x2013;e1015. doi: 10.1016/j.neurobiolaging.2011.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.008</ArticleId><ArticleId IdType="pubmed">22118902</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Galbiati M., Boncoraglio A., Rusmini P., Onesto E., Giorgetti E., Cristofani R., Zito A., Poletti A. Motoneuronal and muscle-selective removal of ALS-related misfolded proteins. Biochem. Soc. Trans. 2013;41:1598&#x2013;1604. doi: 10.1042/BST20130118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20130118</ArticleId><ArticleId IdType="pubmed">24256261</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemenschneider H., Guo Q., Bader J., Frottin F., Farny D., Kleinberger G., Haass C., Mann M., Hartl F.U., Baumeister W., et al. Gel-like inclusions of C-terminal fragments of TDP-43 sequester stalled proteasomes in neurons. EMBO Rep. 2022;23:e53890. doi: 10.15252/embr.202153890.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202153890</ArticleId><ArticleId IdType="pmc">PMC9171420</ArticleId><ArticleId IdType="pubmed">35438230</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Coyne A.N., Pei F., Vaughan S., Chaung M., Zarnescu D.C., Buchan J.R. Endocytosis regulates TDP-43 toxicity and turnover. Nat. Commun. 2017;8:2092. doi: 10.1038/s41467-017-02017-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02017-x</ArticleId><ArticleId IdType="pmc">PMC5727062</ArticleId><ArticleId IdType="pubmed">29233983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaganovich D., Kopito R., Frydman J. Misfolded proteins partition between two distinct quality control compartments. Nature. 2008;454:1088&#x2013;1095. doi: 10.1038/nature07195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07195</ArticleId><ArticleId IdType="pmc">PMC2746971</ArticleId><ArticleId IdType="pubmed">18756251</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Villanueva J.F., D&#xed;az-Molina R., Garc&#xed;a-Gonz&#xe1;lez V. Protein Folding and Mechanisms of Proteostasis. Int. J. Mol. Sci. 2015;16:17193&#x2013;17230. doi: 10.3390/ijms160817193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160817193</ArticleId><ArticleId IdType="pmc">PMC4581189</ArticleId><ArticleId IdType="pubmed">26225966</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., Lambert-Smith I.A., Warraich S.T., Blair I.P., Saunders D.N., Hatters D.M., Yerbury J.J. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 2015;5:13416. doi: 10.1038/srep13416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13416</ArticleId><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg S.J., Lyakhovetsky R., Werdiger A.C., Gitler A.D., Soen Y., Kaganovich D. Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity. Proc. Natl. Acad. Sci. USA. 2012;109:15811&#x2013;15816. doi: 10.1073/pnas.1205829109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1205829109</ArticleId><ArticleId IdType="pmc">PMC3465386</ArticleId><ArticleId IdType="pubmed">22967507</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M., Massignan T., Samengo G., Cheroni C., De Biasi S., Salmona M., Bendotti C., Bonetto V. Insoluble mutant SOD1 is partly oligoubiquitinated in amyotrophic lateral sclerosis mice. J. Biol. Chem. 2006;281:33325&#x2013;33335. doi: 10.1074/jbc.M603489200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M603489200</ArticleId><ArticleId IdType="pubmed">16943203</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., Lambert-Smith I., Mitchell K., McKenna J., McAlary L., Ciryam P., Vine K.L., Saunders D.N., Yerbury J.J. SOD1(A4V) aggregation alters ubiquitin homeostasis in a cell model of ALS. J. Cell Sci. 2018;131:jcs209122. doi: 10.1242/jcs.209122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.209122</ArticleId><ArticleId IdType="pmc">PMC6919637</ArticleId><ArticleId IdType="pubmed">29748379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciryam P., Lambert-Smith I.A., Bean D.M., Freer R., Cid F., Tartaglia G.G., Saunders D.N., Wilson M.R., Oliver S.G., Morimoto R.I., et al. Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc. Natl. Acad. Sci. USA. 2017;114:E3935&#x2013;E3943. doi: 10.1073/pnas.1613854114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1613854114</ArticleId><ArticleId IdType="pmc">PMC5441770</ArticleId><ArticleId IdType="pubmed">28396410</ArticleId></ArticleIdList></Reference><Reference><Citation>Olzscha H., Schermann S.M., Woerner A.C., Pinkert S., Hecht M.H., Tartaglia G.G., Vendruscolo M., Hayer-Hartl M., Hartl F.U., Vabulas R.M. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell. 2011;144:67&#x2013;78. doi: 10.1016/j.cell.2010.11.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.11.050</ArticleId><ArticleId IdType="pubmed">21215370</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida Z.L., Brito R.M.M. Structure and Aggregation Mechanisms in Amyloids. Molecules. 2020;25:1195. doi: 10.3390/molecules25051195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25051195</ArticleId><ArticleId IdType="pmc">PMC7179426</ArticleId><ArticleId IdType="pubmed">32155822</ArticleId></ArticleIdList></Reference><Reference><Citation>Woerner A.C., Frottin F., Hornburg D., Feng L.R., Meissner F., Patra M., Tatzelt J., Mann M., Winklhofer K.F., Hartl F.U., et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science. 2016;351:173&#x2013;176. doi: 10.1126/science.aad2033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad2033</ArticleId><ArticleId IdType="pubmed">26634439</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya T., Maragkakis M. Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity. Sci. Rep. 2018;8:15575. doi: 10.1038/s41598-018-33964-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-33964-0</ArticleId><ArticleId IdType="pmc">PMC6197261</ArticleId><ArticleId IdType="pubmed">30349096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Deng J., Dong J., Liu J., Bigio E.H., Mesulam M., Wang T., Sun L., Wang L., Lee A.Y., et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15:e1007947. doi: 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez-L&#xf3;pez I., Sancho-Bielsa F.J., Engel T., Garc&#xed;a A.G., Pad&#xed;n J.F. Progressive Mitochondrial SOD1(G93A) Accumulation Causes Severe Structural, Metabolic and Functional Aberrations through OPA1 Down-Regulation in a Mouse Model of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2021;22:8194. doi: 10.3390/ijms22158194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158194</ArticleId><ArticleId IdType="pmc">PMC8347639</ArticleId><ArticleId IdType="pubmed">34360957</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Hu H.Y. Sequestration of cellular interacting partners by protein aggregates: Implication in a loss-of-function pathology. FEBS J. 2016;283:3705&#x2013;3717. doi: 10.1111/febs.13722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13722</ArticleId><ArticleId IdType="pubmed">27016044</ArticleId></ArticleIdList></Reference><Reference><Citation>Medinas D.B., Valenzuela V., Hetz C. Proteostasis disturbance in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2017;26:R91&#x2013;R104. doi: 10.1093/hmg/ddx274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx274</ArticleId><ArticleId IdType="pubmed">28977445</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones C.L., Tepe J.J. Proteasome Activation to Combat Proteotoxicity. Molecules. 2019;24:2841. doi: 10.3390/molecules24152841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24152841</ArticleId><ArticleId IdType="pmc">PMC6696185</ArticleId><ArticleId IdType="pubmed">31387243</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz D.G., Neumann M., Kusaka H., Yokota O., Ishihara K., Terada S., Kuroda S., Mackenzie I.R. FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 2009;118:617&#x2013;627. doi: 10.1007/s00401-009-0598-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0598-9</ArticleId><ArticleId IdType="pubmed">19830439</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Neumann M. Subcortical TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases. Acta Neuropathol. 2020;139:83&#x2013;98. doi: 10.1007/s00401-019-02070-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02070-4</ArticleId><ArticleId IdType="pubmed">31501924</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R.H., Shepherd C.E., Kril J.J., McCann H., McGeachie A., McGinley C., Affleck A., Halliday G.M. Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43. Acta Neuropathol. Commun. 2013;1:33. doi: 10.1186/2051-5960-1-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-33</ArticleId><ArticleId IdType="pmc">PMC4046675</ArticleId><ArticleId IdType="pubmed">24252630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S., Fujioka Y., Okada Y., Riku Y., Udagawa T., Honda D., Yokoi S., Endo K., Ikenaka K., Takagi S., et al. Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes. Cell Rep. 2017;18:1118&#x2013;1131. doi: 10.1016/j.celrep.2017.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.01.013</ArticleId><ArticleId IdType="pubmed">28147269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S., Riku Y., Fujioka Y., Endo K., Iwade N., Kawai K., Ishibashi M., Yokoi S., Katsuno M., Watanabe H., et al. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases. Brain. 2020;143:2398&#x2013;2405. doi: 10.1093/brain/awaa196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa196</ArticleId><ArticleId IdType="pubmed">32770214</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiloca C., Goldwurm S., Calcagno N., Verde F., Peverelli S., Calini D., Zecchinelli A.L., Sangalli D., Ratti A., Pezzoli G., et al. TARDBP mutations in a cohort of Italian patients with Parkinson&#x2019;s disease and atypical parkinsonisms. Front. Aging Neurosci. 2022;14:1020948. doi: 10.3389/fnagi.2022.1020948.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1020948</ArticleId><ArticleId IdType="pmc">PMC9557978</ArticleId><ArticleId IdType="pubmed">36247987</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Duan Y., Qin C., Li J.C., Duan G., Deng X., Ni J., Cao X., Xiang K., Tian K., et al. Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis. 2018;9:953. doi: 10.1038/s41419-018-1022-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1022-y</ArticleId><ArticleId IdType="pmc">PMC6148241</ArticleId><ArticleId IdType="pubmed">30237395</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita R., Beck G., Yonenobu Y., Inoue K., Mitsutake A., Ishiura H., Hasegawa M., Murayama S., Mochizuki H. TDP-43 Proteinopathy Presenting with Typical Symptoms of Parkinson&#x2019;s Disease. Mov. Disord. 2022;37:1561&#x2013;1563. doi: 10.1002/mds.29048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.29048</ArticleId><ArticleId IdType="pubmed">35531755</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson J.L., Lee E.B., Xie S.X., Rennert L., Suh E., Bredenberg C., Caswell C., Van Deerlin V.M., Yan N., Yousef A., et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain. 2018;141:2181&#x2013;2193. doi: 10.1093/brain/awy146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy146</ArticleId><ArticleId IdType="pmc">PMC6022546</ArticleId><ArticleId IdType="pubmed">29878075</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H.S., Yu L., White C.C., Chibnik L.B., Chhatwal J.P., Sperling R.A., Bennett D.A., Schneider J.A., De Jager P.L. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE &#x3b5;4 haplotype status: A community-based cohort study. Lancet Neurol. 2018;17:773&#x2013;781. doi: 10.1016/S1474-4422(18)30251-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30251-5</ArticleId><ArticleId IdType="pmc">PMC6154505</ArticleId><ArticleId IdType="pubmed">30093249</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih Y.H., Tu L.H., Chang T.Y., Ganesan K., Chang W.W., Chang P.S., Fang Y.S., Lin Y.T., Jin L.W., Chen Y.R. TDP-43 interacts with amyloid-&#x3b2;, inhibits fibrillization, and worsens pathology in a model of Alzheimer&#x2019;s disease. Nat. Commun. 2020;11:5950. doi: 10.1038/s41467-020-19786-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19786-7</ArticleId><ArticleId IdType="pmc">PMC7683652</ArticleId><ArticleId IdType="pubmed">33230138</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs K.A., Dickson D.W., Tosakulwong N., Weigand S.D., Murray M.E., Petrucelli L., Liesinger A.M., Senjem M.L., Spychalla A.J., Knopman D.S., et al. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer&#x2019;s disease: A longitudinal retrospective study. Lancet Neurol. 2017;16:917&#x2013;924. doi: 10.1016/S1474-4422(17)30284-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30284-3</ArticleId><ArticleId IdType="pmc">PMC5646369</ArticleId><ArticleId IdType="pubmed">28919059</ArticleId></ArticleIdList></Reference><Reference><Citation>Matej R., Tesar A., Rusina R. Alzheimer&#x2019;s disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview. Clin. Biochem. 2019;73:26&#x2013;31. doi: 10.1016/j.clinbiochem.2019.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2019.08.005</ArticleId><ArticleId IdType="pubmed">31400306</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalbano M., McAllen S., Cascio F.L., Sengupta U., Garcia S., Bhatt N., Ellsworth A., Heidelman E.A., Johnson O.D., Doskocil S., et al. TDP-43 and Tau Oligomers in Alzheimer&#x2019;s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia. Neurobiol. Dis. 2020;146:105130. doi: 10.1016/j.nbd.2020.105130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105130</ArticleId><ArticleId IdType="pmc">PMC7703712</ArticleId><ArticleId IdType="pubmed">33065281</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Davies K.M., Cottam V., Genoud S., Ortega R., Roudeau S., Carmona A., De Silva K., Wasinger V., Lewis S.J.G., et al. Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson&#x2019;s disease brain. Acta Neuropathol. 2017;134:113&#x2013;127. doi: 10.1007/s00401-017-1726-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1726-6</ArticleId><ArticleId IdType="pubmed">28527045</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe H., Nakanishi H. Effect of pH on the aggregate formation of a non-amyloid component (1&#x2013;13) J. Pept. Sci. 2003;9:177&#x2013;186. doi: 10.1002/psc.444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/psc.444</ArticleId><ArticleId IdType="pubmed">12675500</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J., Rees H.D., Weintraub S.T., Levey A.I., Chin L.S., Li L. Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J. Biol. Chem. 2005;280:11648&#x2013;11655. doi: 10.1074/jbc.M414327200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M414327200</ArticleId><ArticleId IdType="pubmed">15659387</ArticleId></ArticleIdList></Reference><Reference><Citation>St-Amour I., Turgeon A., Goupil C., Planel E., H&#xe9;bert S.S. Co-occurrence of mixed proteinopathies in late-stage Huntington&#x2019;s disease. Acta Neuropathol. 2018;135:249&#x2013;265. doi: 10.1007/s00401-017-1786-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1786-7</ArticleId><ArticleId IdType="pubmed">29134321</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampedro F., Mart&#xed;nez-Horta S., P&#xe9;rez-P&#xe9;rez J., P&#xe9;rez-Gonz&#xe1;lez R., Horta-Barba A., Campolongo A., Izquierdo C., Aracil-Bola&#xf1;os I., Rivas E., Puig-Davi A., et al. Plasma TDP-43 Reflects Cortical Neurodegeneration and Correlates with Neuropsychiatric Symptoms in Huntington&#x2019;s Disease. Clin. Neuroradiol. 2022;32:1077&#x2013;1085. doi: 10.1007/s00062-022-01150-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00062-022-01150-5</ArticleId><ArticleId IdType="pubmed">35238950</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozales K., Younis A., Saida N., Meller A., Goldman H., Kellerman L., Heinrich R., Berlin S., Shalgi R. Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens. Nat. Commun. 2022;13:516. doi: 10.1038/s41467-022-27982-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-27982-w</ArticleId><ArticleId IdType="pmc">PMC8792056</ArticleId><ArticleId IdType="pubmed">35082301</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta U., Kayed R. Amyloid &#x3b2;, Tau, and &#x3b1;-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases. Prog. Neurobiol. 2022;214:102270. doi: 10.1016/j.pneurobio.2022.102270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2022.102270</ArticleId><ArticleId IdType="pubmed">35447272</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A., Chi&#xf2; A., Pagani M., Cammarosano S., Dematteis F., Moglia C., Solero L., Manera U., Martone T., Brunetti M., et al. Parkinsonian traits in amyotrophic lateral sclerosis (ALS): A prospective population-based study. J. Neurol. 2019;266:1633&#x2013;1642. doi: 10.1007/s00415-019-09305-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09305-0</ArticleId><ArticleId IdType="pubmed">30949819</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty M.J., Bird T.D., Leverenz J.B. &#x3b1;-synuclein in motor neuron disease: An immunohistologic study. Acta Neuropathol. 2004;107:169&#x2013;175. doi: 10.1007/s00401-003-0790-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-003-0790-2</ArticleId><ArticleId IdType="pubmed">14648076</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezey E., Dehejia A., Harta G., Papp M.I., Polymeropoulos M.H., Brownstein M.J. Alpha synuclein in neurodegenerative disorders: Murderer or accomplice? Nat. Med. 1998;4:755&#x2013;757. doi: 10.1038/nm0798-755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0798-755</ArticleId><ArticleId IdType="pubmed">9662355</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung Y.H., Joo K.M., Kim M.J., Cha C.I. Immunohistochemical study on the distribution of alpha-synuclein in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation. Neurosci. Lett. 2003;342:151&#x2013;154. doi: 10.1016/S0304-3940(03)00237-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(03)00237-4</ArticleId><ArticleId IdType="pubmed">12757887</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch Y., Helferich A.M., Steinacker P., Oeckl P., Walther P., Weishaupt J.H., Danzer K.M., Otto M. Aggregated &#x3b1;-Synuclein Increases SOD1 Oligomerization in a Mouse Model of Amyotrophic Lateral Sclerosis. Am. J. Pathol. 2016;186:2152&#x2013;2161. doi: 10.1016/j.ajpath.2016.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2016.04.008</ArticleId><ArticleId IdType="pubmed">27322773</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman M., Elman L., McCluskey L., McMillan C.T., Boller A., Powers J., Rascovsky K., Hu W., Shaw L., Irwin D.J., et al. Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis. JAMA Neurol. 2014;71:442&#x2013;448. doi: 10.1001/jamaneurol.2013.6064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.6064</ArticleId><ArticleId IdType="pmc">PMC3989393</ArticleId><ArticleId IdType="pubmed">24492862</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnello L., Colletti T., Lo Sasso B., Vidali M., Spataro R., Gambino C.M., Giglio R.V., Piccoli T., Bivona G., La Bella V., et al. Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis. Eur. J. Neurol. 2021;28:1868&#x2013;1875. doi: 10.1111/ene.14789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14789</ArticleId><ArticleId IdType="pubmed">33638255</ArticleId></ArticleIdList></Reference><Reference><Citation>Vintilescu C.R., Afreen S., Rubino A.E., Ferreira A. The Neurotoxic TAU(45-230) Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects. Mol. Med. 2016;22:477&#x2013;486. doi: 10.2119/molmed.2016.00095.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2016.00095</ArticleId><ArticleId IdType="pmc">PMC5072411</ArticleId><ArticleId IdType="pubmed">27496042</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Iwata M. Immunoreactivity of &#x3b2;-amyloid precursor protein in amyotrophic lateral sclerosis. Acta Neuropathol. 1999;97:463&#x2013;468. doi: 10.1007/s004010051015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010051015</ArticleId><ArticleId IdType="pubmed">10334483</ArticleId></ArticleIdList></Reference><Reference><Citation>Calingasan N.Y., Chen J., Kiaei M., Beal M.F. &#x3b2;-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol. Dis. 2005;19:340&#x2013;347. doi: 10.1016/j.nbd.2005.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.01.012</ArticleId><ArticleId IdType="pubmed">15837590</ArticleId></ArticleIdList></Reference><Reference><Citation>Colletti T., Agnello L., Spataro R., Guccione L., Notaro A., Lo Sasso B., Blandino V., Graziano F., Gambino C.M., Giglio R.V., et al. Prognostic Role of CSF &#x3b2;-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis. Brain Sci. 2021;11:302. doi: 10.3390/brainsci11030302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030302</ArticleId><ArticleId IdType="pmc">PMC7997395</ArticleId><ArticleId IdType="pubmed">33673569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafuri F., Ronchi D., Magri F., Comi G.P., Corti S. SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis. Front. Cell. Neurosci. 2015;9:336. doi: 10.3389/fncel.2015.00336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00336</ArticleId><ArticleId IdType="pmc">PMC4548205</ArticleId><ArticleId IdType="pubmed">26379505</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>